SCHEMBL5503138

SCHEMBL5503138

Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H]3CCCC[C@H]3C2)cc1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3534067 1.00 BDKRB1 (0.62) BDKRB1
SCHEMBL3537646 1.00 BDKRB1 (0.62) BDKRB1
SCHEMBL3536995 0.86 BDKRB1 (0.54) BDKRB1
SCHEMBL3533012 0.86 BDKRB1 (0.54) BDKRB1
SCHEMBL3534638 0.86 BDKRB1 (0.54) BDKRB1
SCHEMBL3530112 0.86 BDKRB1 (0.54) BDKRB1
SCHEMBL3534250 0.86 BDKRB1 (0.66) BDKRB1
SCHEMBL4181152 0.86 BDKRB1 (0.68) BDKRB1
SCHEMBL4177184 0.84 BDKRB1 (0.60) BDKRB1
SCHEMBL4169701 0.83 BDKRB1 (0.65) BDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817294-A1 1,2,3,4-TETRAHYDROPYRAZIN-2-YL ACETAMIDES AND THEIR USE AS BRADYKININ ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION RELATED DISORDERS Amgen Inc. (US) 2007-08-15 EP claimed
WO-2006019975-A1 1,2,3,4-TETRAHYDROPYRAZIN-2-YL ACETAMIDES AND THEIR USE AS BRADYKININ ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION RELATED DISORDERS AMGEN INC. (US) 2006-02-23 WO claimed